SOURCE: Universal Detection Technology

August 12, 2008 16:00 ET

Universal Detection Technology Receives Purchase Order for Anthrax Detection Equipment From the State of Hawaii Emergency Medical Services

Hawaii Purchases Handheld Assays for Anthrax, and Other Bioterrorism Weapons, Detection

LOS ANGELES, CA--(Marketwire - August 12, 2008) - Universal Detection Technology ( (OTCBB: UNDT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has received a purchase order from the state of Hawaii Emergency Medical Services for its handheld bio-detection equipment. The purchase order is for handheld devices that test for Anthrax, Ricin Toxin, Botulinum Toxin, Y. Pestis (Plague), and Staphylococcal Entertoxin B (SEB). The purchase order also includes simulation kits that mimic a real world "white powder" incident.

UNDT has supplied its biological test equipment to first responders throughout the country including the Washington, D.C. Fire and Emergency Medical Services and the City of Burbank Fire Department. This order, however, marks the Company's first order from a State Government. The equipment is also used by the U.S. DOD to train first responders on the proper use of the equipment at the Dugway Proving Grounds in Utah.

UNDT's Biological test kits are designed to test for Anthrax, Ricin, Botulinum Toxin, Plague and SEBs in as little as 3 minutes. UNDT has also supplied its test kits for site protection at the Beijing Olympics. UNDT's simulation/trainer equipment and threat simulation powders are designed to mimic bio-threat events.

"We are proud to be supplying our test equipment to first responders throughout the nation and to be supplying the Sate of Hawaii," said Mr. Jacques Tizabi, UNDT's Chief Executive Officer.

For more information please visit our website at or

Email us at

About Universal Detection Technology

Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. For more information, please visit

Forward-Looking Statements

Except for historical information contained herein, the statements in this news release are forward-looking statements that involve known and unknown risks and uncertainties, which may cause the Company's actual results, performance and achievement in the future to differ materially from forecasted results, performance, and achievement. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company's plans or expectations.

Contact Information